Skip to main content
. 2024 Mar 22;11:1290907. doi: 10.3389/fmed.2024.1290907

Table 2.

Diagnosis distribution among the participants.

Diagnosis Total (n = 301) Control (n = 144) Intervention (n = 157)
End-stage renal disease 85 (28.2%) 38 (26.4%) 47 (29.9%)
Chronic respiratory disease with complication 63 (20.9%) 27(18.8%) 36 (22.9%)
Complicated HIV 63 (20.9%) 33 (22.9%) 30 (19.1%)
Heart failure 52 (17.2%) 26 (18.1%) 26 (16.6%)
Chronic liver disease 19 (6.3%) 9 (6.3%) 10 (6.4%)
Neurological disorder 17 (5.64%) 10 (6.9%) 7 (4.5%)
Others 2 (0.66%) 1 (0.7%) 1 (0.6%)